PUTHENPARAMPIL, MARCO
PUTHENPARAMPIL, MARCO
Dipartimento di Neuroscienze - DNS
A comparison of natalizumab's effects on SDMT between pediatric-onset and adult-onset multiple sclerosis patients.
2024 Puthenparampil, M; Scialpi, G; Gaggiola, M; Zanotelli, G; Miscioscia, A; Berardi, A; Riccardi, A; Nosadini, M; Sartori, S; Perini, P; Rinaldi, F; Gallo, P
A new T2 lesion in a patient with the clinically isolated syndrome does not necessarily imply a conversion to multiple sclerosis
2018 Capone, Fioravante; Puthenparampil, Marco; Mallio, Carlo Augusto; Celia, Alessandra Ida; Florio, Lucia; Gallo, Paolo; Di Lazzaro, Vincenzo
Acute simultaneous development of brain tumour–like lesion and demyelinating polyneuropathy in a patient with chronic relapsing myelitis
2018 Puthenparampil, Marco; Terrin, Alberto; Federle, Lisa; Gizzi, Matteo; Perini, Paola; Gallo, Paolo
Alemtuzumab as rescue therapy in case of multiple sclerosis rebound following Natalizumab break: Clinical case and literature review
2019 Federle, Lisa; Puthenparampil, Marco; Stenta, Gianola; Gallo, Paolo; Perini, Francesco
Alemtuzumab following natalizumab is more effective in adult-onset than paediatric-onset multiple sclerosis
2023 Puthenparampil, M; Gaggiola, M; Miscioscia, A; Mauceri, Va; De Napoli, F; Zanotelli, G; Anglani, M; Nosadini, M; Sartori, S; Perini, P; Rinaldi, F; Gallo, P
Altered CSF Albumin Quotient Links Peripheral Inflammation and Brain Damage in MS
2021 Puthenparampil, Marco; Tomas-Ojer, Paula; Hornemann, Thorsten; Lutterotti, Andreas; Jelcic, Ilijas; Ziegler, Mario; J Hülsmeier, Andreas; Cruciani, Carolina; Faigle, Wolfgang; Martin, Roland; Sospedra, Mireia
Association of Multiple Sclerosis with PM 2.5 levels. Further evidence from the highly polluted area of Padua Province, Italy
2021 Scartezzini, A.; Tateo, F.; Perini, P.; Benacchio, L.; Ermani, M.; Ferro, A.; Cadaldini, M.; Piccinno, M. G.; Colledan, L.; Freddi, N.; Gallo, P.; Puthenparampil, M.
BAFF Index and CXCL13 levels in the cerebrospinal fluid associate respectively with intrathecal IgG synthesis and cortical atrophy in multiple sclerosis at clinical onset
2017 Puthenparampil, M.; Federle, L.; Miante, S.; Zito, Alberto; Toffanin, E.; Ruggero, S.; Ermani, M.; Pravato, S.; Poggiali, D.; Perini, P.; Rinaldi, F.; Gallo, P.
BAFF is decreased in the cerebrospinal fluid of multiple sclerosis at clinical onset
2016 Puthenparampil, M; Miante, S; Federle, L; Zanetta, Chiara; Toffanin, E; Ruggero, S; Rinaldi, F; Gallo, P
Blood biomarkers for Alzheimer’s disease with the Lumipulse automated platform: Age-effect and clinical value interpretation
2024 Musso, Giulia; Gabelli, Carlo; Puthenparampil, Marco; Cosma, Chiara; Cagnin, Annachiara; Gallo, Paolo; Sorarù, Gianni; Pegoraro, Elena; Zaninotto, Martina; Antonini, Angelo; Moz, Stefania; Zambon, Carlo Federico; Plebani, Mario; Corbetta, Maurizio; Basso, Daniela
Blood-brain barrier damage associates with glia-related cytokines in the cerebrospinal fluid of patients with Multiple Sclerosis
2024 Puthenparampil, M; Marin, A; Zanotelli, G; Mauceri, V A; De Napoli, F; Gaggiola, M; Miscioscia, A; Ponzano, M; Bovis, F; Perini, P; Rinaldi, F; Molon, B; Gallo, P
Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4+ T Cells in Multiple Sclerosis
2019 Faigle, Wolfgang; Cruciani, Carolina; Wolski, Witold; Roschitzki, Bernd; Puthenparampil, Marco; Tomas-Ojer, Paula; Sellés-Moreno, Carla; Zeis, Thomas; Jelcic, Ivan; Schaeren-Wiemers, Nicole; Sospedra, Mireia; Martin, Roland
Bruton tyrosine kinase inhibitors: can they be optimized for the treatment of neuroinflammatory disorders?
2023 Visentin, Andrea; Puthenparampil, Marco; Briani, Chiara
Case report: Breaking CNS immuno-privilege: TNFα-inhibitor triggers aseptic meningitis in a patient with rheumatoid arthritis
2024 Kassabian, Benedetta; Facco, Monica; Miscioscia, Alessandro; Carraro, Samuela; Rinaldi, Francesca; Gallo, Paolo; Puthenparampil, Marco
Case Report: Para-infectious cranial nerve palsy after bacterial meningitis
2022 Zanotelli, Giovanni; Bresciani, Lorenzo; Anglani, Mariagiulia; Miscioscia, Alessandro; Rinaldi, Francesca; Puthenparampil, Marco
Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset
2014 Seppi, Dario; Puthenparampil, Marco; Federle, Lisa; Ruggero, Susanna; Toffanin, Elisabetta; Rinaldi, Francesca; Perini, Paola; Gallo, Paolo
Characterization of Antigen-Induced CD4+ T-Cell Senescence in Multiple Sclerosis
2022 Tomas-Ojer, Paula; Puthenparampil, Marco; Hornemann, Thorsten; Lutterotti, Andreas; Jelcic, Ilijas; Ziegler, Mario; J Hülsmeier, Andreas; Cruciani, Carolina; Faigle, Wolfgang; Martin, Roland; Sospedra., Mireia
Clinical Profiles in Multiple Sclerosis: Cognitive Reserve and Motor Impairment along Disease Duration
2023 Maffezzini, Sabrina; Pucci, Veronica; Riccardi, Alice; Montemurro, Sonia; Puthenparampil, Marco; Perini, Paola; Rinaldi, Francesca; Gallo, Paolo; Arcara, Giorgio; Mondini, Sara
Cortical lesions and cognitive impairment in multiple sclerosis.
2010 Rinaldi, Francesca; Calabrese, Massimiliano; Grossi, P; Puthenparampil, M; Perini, Paola; Gallo, Paolo
Cortical relapses in multiple sclerosis
2015 Puthenparampil, Marco; Poggiali, Davide; Causin, Francesco; Rolma, Giuseppe; Rinaldi, Francesca; Perini, Paola; Gallo, Paolo